ES2180922T3 - Comprimidos de alto contenido en famciclovir. - Google Patents

Comprimidos de alto contenido en famciclovir.

Info

Publication number
ES2180922T3
ES2180922T3 ES97901539T ES97901539T ES2180922T3 ES 2180922 T3 ES2180922 T3 ES 2180922T3 ES 97901539 T ES97901539 T ES 97901539T ES 97901539 T ES97901539 T ES 97901539T ES 2180922 T3 ES2180922 T3 ES 2180922T3
Authority
ES
Spain
Prior art keywords
famciclovir
high content
content tablets
tablets
percentage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97901539T
Other languages
English (en)
Inventor
Michael John Greenway
Jennifer Mary Slater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Application granted granted Critical
Publication of ES2180922T3 publication Critical patent/ES2180922T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBE UN COMPRIMIDO FARMACEUTICO EN EL CUAL EL FAMCICLOVIR ES EL PRINCIPIO ACTIVO, Y EN EL CUAL EL PORCENTAJE EN PESO DE FAMCICLOVIR EN EL COMPRIMIDO ES DE UN 85 % O MAYOR.
ES97901539T 1996-01-16 1997-01-13 Comprimidos de alto contenido en famciclovir. Expired - Lifetime ES2180922T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ES2180922T3 true ES2180922T3 (es) 2003-02-16

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97901539T Expired - Lifetime ES2180922T3 (es) 1996-01-16 1997-01-13 Comprimidos de alto contenido en famciclovir.

Country Status (38)

Country Link
US (1) US6765007B1 (es)
EP (1) EP0874632B1 (es)
JP (2) JP4711360B2 (es)
KR (1) KR100338829B1 (es)
CN (1) CN1132582C (es)
AP (2) AP747A (es)
AR (1) AR005456A1 (es)
AT (1) ATE220910T1 (es)
AU (1) AU713090B2 (es)
BG (1) BG63488B1 (es)
BR (1) BR9706982A (es)
CY (1) CY2390B1 (es)
CZ (1) CZ287205B6 (es)
DE (1) DE69714215T2 (es)
DK (1) DK0874632T3 (es)
DZ (1) DZ2159A1 (es)
EA (1) EA001946B1 (es)
EG (1) EG23684A (es)
ES (1) ES2180922T3 (es)
GB (1) GB9600847D0 (es)
HK (1) HK1016473A1 (es)
HU (1) HU225472B1 (es)
IL (1) IL124913A0 (es)
MX (1) MX9805713A (es)
MY (1) MY127527A (es)
NO (1) NO315689B1 (es)
NZ (1) NZ326769A (es)
OA (1) OA10812A (es)
PE (1) PE35498A1 (es)
PL (1) PL187291B1 (es)
PT (1) PT874632E (es)
SK (1) SK282132B6 (es)
TR (1) TR199800954T2 (es)
TW (1) TW434016B (es)
UA (1) UA63897C2 (es)
UY (2) UY24437A1 (es)
WO (1) WO1997025990A1 (es)
ZA (1) ZA97310B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
US10543166B2 (en) 2009-06-26 2020-01-28 Taris Biomedical Llc Implantable drug delivery devices and methods of making the same
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
EP0522128B1 (en) * 1991-01-30 1996-01-17 The Wellcome Foundation Limited Water-dispersible tablets
HUT67392A (en) 1991-05-15 1995-04-28 Univ Yale Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) * 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
DK0874632T3 (da) 2002-11-11
AP1114A (en) 2002-10-18
UY24437A1 (es) 1997-06-06
JP4711360B2 (ja) 2011-06-29
WO1997025990A1 (en) 1997-07-24
AP747A (en) 1999-05-03
MY127527A (en) 2006-12-29
PL327922A1 (en) 1999-01-04
ZA97310B (en) 1997-10-23
MX9805713A (es) 1998-10-31
SK95698A3 (en) 1999-01-11
CZ287205B6 (en) 2000-10-11
GB9600847D0 (en) 1996-03-20
SK282132B6 (sk) 2001-11-06
BR9706982A (pt) 1999-07-20
CN1132582C (zh) 2003-12-31
OA10812A (en) 2003-01-29
UA63897C2 (en) 2004-02-16
HUP9901021A2 (hu) 1999-08-30
AR005456A1 (es) 1999-06-23
EG23684A (en) 2007-05-09
NZ326769A (en) 2000-05-26
PT874632E (pt) 2002-10-31
CZ225498A3 (cs) 1998-12-16
TR199800954T2 (xx) 1998-10-21
NO983259L (no) 1998-07-15
JP2009091362A (ja) 2009-04-30
EA199800573A1 (ru) 1999-02-25
DE69714215T2 (de) 2003-01-23
EP0874632B1 (en) 2002-07-24
DE69714215D1 (de) 2002-08-29
HU225472B1 (en) 2006-12-28
PL187291B1 (pl) 2004-06-30
EP0874632A1 (en) 1998-11-04
US6765007B1 (en) 2004-07-20
BG102638A (en) 1999-07-30
EA001946B1 (ru) 2001-10-22
NO983259D0 (no) 1998-07-15
ATE220910T1 (de) 2002-08-15
BG63488B1 (bg) 2002-03-29
UY24556A1 (es) 2001-08-27
TW434016B (en) 2001-05-16
DZ2159A1 (fr) 2002-12-01
AU1541897A (en) 1997-08-11
NO315689B1 (no) 2003-10-13
AP9801298A0 (en) 1998-09-30
HUP9901021A3 (en) 2000-08-28
CY2390B1 (en) 2004-09-10
HK1016473A1 (en) 1999-11-05
AP9700911A0 (en) 1997-01-31
KR19990077229A (ko) 1999-10-25
AU713090B2 (en) 1999-11-25
PE35498A1 (es) 1998-08-07
CN1208350A (zh) 1999-02-17
IL124913A0 (en) 1999-01-26
JP2000503311A (ja) 2000-03-21
KR100338829B1 (ko) 2002-07-18

Similar Documents

Publication Publication Date Title
MX9304967A (es) Tabletas de liberacion sostenida controlada.
DE69801369D1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
NZ507271A (en) Fast disintegrating tablets
ATE177630T1 (de) Gegen missbrauch geschuetzte tabletten
SE0003449D0 (sv) Anticancer compositions
AU9163701A (en) Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
BG103714A (en) Pararacetamol-containing tablet
ES2193155T3 (es) Taxanos que tienen la cadena lateral sustituida por furilo o tienilo.
WO2005007137A3 (de) Ambroxolhaltige tabletten
ES2143180T3 (es) Composiciones farmaceuticas en forma de comprimidos de liberacion prolongada a base de granulados de polisacaridos de elevado peso molecular.
YU72194A (sh) Injekcione suspenzije sa produženim dejstvom i postupak za proizvodnju istih
ES2180922T3 (es) Comprimidos de alto contenido en famciclovir.
ATE128363T1 (de) Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.
ATE87468T1 (de) Antacidatabletten.
NO943070D0 (no) Antitussiva
MXPA04003851A (es) Antipruriticos.
ATE269061T1 (de) Calciumhaltige brausetablette mit einem antihistaminikum als wirkstoff
DE859635T1 (de) Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine
ECSP971997A (es) Nueva formulacion de un producto farmaceutico
ATE266412T1 (de) Pharmazeutische zubereitung enthaltend dithranol
AR012575A1 (es) Edulcorante natural